101.00
0.00
(0.00%)
At close: January 31 at 8:43:02 AM GMT+1
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | -- | -- | -- | -- |
Avg. Estimate | 0 | 0 | 0 | 0 |
Low Estimate | 0 | 0 | 0 | 0 |
High Estimate | 0 | 0 | 0 | 0 |
Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 10 | 9 | 12 | 12 |
Avg. Estimate | 470.83M | 356.89M | 1.48B | 1.58B |
Low Estimate | 427.04M | 349.1M | 1.43B | 1.54B |
High Estimate | 494.81M | 363M | 1.5B | 1.62B |
Year Ago Sales | 474.23M | 330.15M | 1.43B | 1.48B |
Sales Growth (year/est) | -0.72% | 8.10% | 3.12% | 7.06% |
EPS Trend
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Current Estimate | 0 | 0 | 0 | 0 |
7 Days Ago | 0 | 0 | 0 | 0 |
30 Days Ago | 0 | 0 | 0 | 0 |
60 Days Ago | 0 | 0 | 0 | 0 |
90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
PEA.F | -- | -- | -- | -- |
S&P 500 | 9.91% | 10.33% | 14.01% | 13.75% |
Upgrades & Downgrades
Maintains | Barclays: Equal-Weight to Equal-Weight | 1/31/2025 |
Maintains | Wedbush: Outperform to Outperform | 1/24/2025 |
Maintains | RBC Capital: Outperform to Outperform | 1/3/2025 |
Maintains | Citigroup: Buy to Buy | 12/18/2024 |
Maintains | Barclays: Equal-Weight to Equal-Weight | 10/25/2024 |
Maintains | Wedbush: Outperform to Outperform | 10/25/2024 |